Christopher Dall

MedStar Washington Hospital Center

Papers

3

Total Citations

23

H-Index

2

About

Christopher Dall is a urologic surgeon and researcher whose work centers on advancing surgical techniques for prostate cancer, with a particular focus on optimizing functional outcomes without compromising oncologic efficacy. His primary research areas include robotic-assisted radical prostatectomy, Retzius-sparing approaches, and salvage procedures for recurrent disease. Dall’s most impactful contribution is his 2024 single-surgeon series comparing pelvic-fascia sparing robotic prostatectomy to standard technique, demonstrating superior urinary function and quality of life with no sacrifice in cancer control—a finding with direct implications for patient counseling and surgical practice. His 2022 review of salvage Retzius-sparing prostatectomy addresses the critical challenge of managing radiation failure, offering a pathway to reduce historically high complication and incontinence rates. Dall has also contributed to the literature on rare postoperative complications, such as a 2021 case report of a complex lymphocele causing iliac compression and pulmonary embolism. With over 20 citations across his key works, Dall is establishing himself as a thoughtful contributor to the evolution of prostate cancer surgery, particularly in the pursuit of techniques that preserve patients’ quality of life.

Research Focus

Key Achievements

2
H-Index
3
Papers
23
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Long-term outcomes of pelvic-fascia sparing robotic-assisted radical prostatectomy versus standard technique: Superior urinary function and quality of life without compromising oncologic efficacy in a single-surgeon series
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: MedStar Washington Hospital Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago